ICD-10 Specific code J39.3: Upper respiratory tract hypersensitivity reaction, site unspecified
Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
Translations
| Language | Translation |
|---|---|
English
|
Upper respiratory tract hypersensitivity reaction, site unspecified |
French
|
Réaction anaphylactique des voies respiratoires supérieures, localisation non précisée |
Hierarchical position
| Level | Code | Title | |
|---|---|---|---|
| 1 | X | Diseases of the respiratory system | |
| 2 | J30-J39 | Other diseases of upper respiratory tract | |
| 3 | J39 | Other diseases of upper respiratory tract | |
| 4 | J39.3 | Upper respiratory tract hypersensitivity reaction, site unspecified |
Indicated medicines
| Active Ingredient |
|---|
|
Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates. |
|
Methylprednisolone is a synthetic glucocorticoid and a methyl derivative of prednisolone. Methylprednisolone is a potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system. |
|
Prednisolone is a glucocorticoid which has anti-inflammatory activity. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammatory effects in disorders of many organ systems. |